Higher expression of pseudouridine synthase 7 promotes non-small cell lung cancer progression and suggests a poor prognosis

Table 1 Correlation between the PUS7 expression and clinicopathological characteristics in human NSCLC tissues

	Variables	Cases	PUS7		P
	Variables	Cases	Low expression	High expression	P
Gender	Male	106	66	40	0.119
Gender	Female	75	55	20	0.119
Age (years)	≤ 60	94	62	32	0.791
Age (years)	> 60	87	59	28	0.791
Pathological type	Non-adenocarcinoma	27	14	13	0.073
Pathological type	Adenocarcinoma	154	107	47	0.073
Differentiation	Moderate and poor differentiation	125	86	39	0.405
Differentiation	High differentiation	56	35	21
Clinical stage	Stage IB-IIB	137	94	43	0.486
Clinical stage	Stage IIIA	46	29	17	0.486
Adjuvant chemotherapy	Received	107	67	40	0.146
Adjuvant chemotherapy	Not received	74	54	20	0.146

ISSN: 1749-8090